Drug Pricing Dilemma
David sheds light on the complexities of drug pricing and the lack of incentives for pharmaceutical companies to explore new uses for existing medications. The conversation delves into the challenges of conducting trials on inexpensive generic drugs and the need to bridge the gap in the current system.In this clip
From this podcast
The Jordan Harbinger Show
1005: David Fajgenbaum | Leveraging AI to Cure Rare Diseases
Related Questions
Why are pharmaceuticals so expensive, as discussed in the episode 1005: David Fajgenbaum | Leveraging AI to Cure Rare Diseases and the clip Drug Pricing Dilemma?
Why are prescription drugs so expensive, as discussed in the episode 1005: David Fajgenbaum | Leveraging AI to Cure Rare Diseases and the clip Drug Pricing Dilemma?
Why are prescription drugs so expensive, as discussed in the episode 1005: David Fajgenbaum | Leveraging AI to Cure Rare Diseases and the clip Drug Pricing Dilemma?